4//SEC Filing
Stylli Harry 4
Accession 0001181431-10-027387
CIK 0001340752other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 6:03 PM ET
Size
5.6 KB
Accession
0001181431-10-027387
Insider Transaction Report
Form 4
Stylli Harry
Director
Transactions
- Award
Stock Option (right to buy)
2010-05-13−25,000→ 25,000 totalExercise: $1.85From: 2011-05-13→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]This option is an automatic annual grant.
- [F2]This option terminates on the earlier of (i) ninety (90) days after the reporting person ceases to be a director of the Issuer or (ii) May 13, 2020.
Documents
Issuer
Molecular Insight Pharmaceuticals, Inc.
CIK 0001340752
Entity typeother
Related Parties
1- filerCIK 0001329344
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 6:03 PM ET
- Size
- 5.6 KB